Berkeley, CA, United States of America

Rayka Yokoo

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2021.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rayka Yokoo: Innovator in RNA-Guided Polypeptides

Introduction

Rayka Yokoo is an accomplished inventor based in Berkeley, CA. He has made significant contributions to the field of biotechnology, particularly in the development of RNA-guided polypeptides. His innovative work has the potential to advance various applications in genetic engineering and molecular biology.

Latest Patents

Rayka Yokoo holds a patent for "Variant RNA-guided polypeptides and methods of use." This patent includes RNA-guided polypeptides, such as circular permuted Cas9 proteins, which feature a unique fusion of N-terminal and C-terminal fragments. The invention also encompasses conditionally active RNA-guided polypeptides and Cas9 fusion polypeptides with internal insertions of heterologous polypeptides. This groundbreaking work opens new avenues for research and application in gene editing technologies.

Career Highlights

Rayka Yokoo is affiliated with the University of California, where he continues to push the boundaries of scientific research. His dedication to innovation has led to the development of cutting-edge technologies that enhance our understanding of genetic manipulation.

Collaborations

Rayka has collaborated with notable scientists, including David Frank Savage and Jennifer A. Doudna. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Rayka Yokoo's contributions to the field of RNA-guided polypeptides exemplify the spirit of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for future applications in genetic engineering.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…